HALO Annual Current Assets
$746.42 M
+$7.41 M+1.00%
31 December 2023
Summary:
As of January 22, 2025, HALO annual total current assets is $746.42 million, with the most recent change of +$7.41 million (+1.00%) on December 31, 2023. During the last 3 years, it has risen by +$191.66 million (+34.55%). HALO annual current assets is now -19.42% below its all-time high of $926.29 million, reached on December 31, 2021.HALO Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HALO Quarterly Current Assets
$1.13 B
+$139.18 M+14.09%
30 September 2024
Summary:
As of January 22, 2025, HALO quarterly total current assets is $1.13 billion, with the most recent change of +$139.18 million (+14.09%) on September 30, 2024. Over the past year, it has increased by +$247.97 million (+28.21%). HALO quarterly current assets is now at all-time high.HALO Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HALO Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.0% | +28.2% |
| 3 y3 years | +34.5% | +28.2% |
| 5 y5 years | +74.5% | +28.2% |
HALO Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -19.4% | +1.0% | at high | +108.0% |
| 5 y | 5-year | -19.4% | +37.4% | at high | +140.8% |
| alltime | all time | -19.4% | >+9999.0% | at high | >+9999.0% |
Halozyme Therapeutics Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.13 B(+14.1%) |
| June 2024 | - | $987.80 M(+13.1%) |
| Mar 2024 | - | $873.58 M(+17.0%) |
| Dec 2023 | $986.85 M(-10.5%) | $746.42 M(-15.1%) |
| Sept 2023 | - | $879.01 M(+14.8%) |
| June 2023 | - | $765.75 M(+24.5%) |
| Mar 2023 | - | $615.02 M(-16.8%) |
| Dec 2022 | $1.10 B(+518.9%) | $739.01 M(+13.1%) |
| Sept 2022 | - | $653.20 M(+20.5%) |
| June 2022 | - | $541.94 M(-45.2%) |
| Mar 2022 | - | $988.69 M(+6.7%) |
| Dec 2021 | $178.14 M(+608.0%) | $926.29 M(-8.9%) |
| Sept 2021 | - | $1.02 B(+1.8%) |
| June 2021 | - | $999.75 M(+6.2%) |
| Mar 2021 | - | $941.72 M(+69.8%) |
| Dec 2020 | $25.16 M(+12.1%) | $554.76 M(+11.2%) |
| Sept 2020 | - | $498.89 M(-0.3%) |
| June 2020 | - | $500.36 M(+6.9%) |
| Mar 2020 | - | $467.97 M(-13.9%) |
| Dec 2019 | $22.44 M(+81.0%) | $543.44 M(+58.9%) |
| Sept 2019 | - | $342.04 M(-12.7%) |
| June 2019 | - | $391.71 M(-4.2%) |
| Mar 2019 | - | $409.04 M(-4.4%) |
| Dec 2018 | $12.40 M(+29.5%) | $427.85 M(-0.5%) |
| Sept 2018 | - | $429.93 M(-6.9%) |
| June 2018 | - | $462.03 M(-4.6%) |
| Mar 2018 | - | $484.47 M(-5.1%) |
| Dec 2017 | $9.57 M(+92.1%) | $510.37 M(+44.4%) |
| Sept 2017 | - | $353.35 M(+3.7%) |
| June 2017 | - | $340.83 M(+53.3%) |
| Mar 2017 | - | $222.35 M(-13.3%) |
| Dec 2016 | $4.98 M(-50.3%) | $256.53 M(-5.9%) |
| Sept 2016 | - | $272.61 M(-4.1%) |
| June 2016 | - | $284.34 M(-4.3%) |
| Mar 2016 | - | $297.04 M(+72.9%) |
| Dec 2015 | $10.02 M(+115.1%) | $171.77 M(+12.2%) |
| Sept 2015 | - | $153.09 M(-9.1%) |
| June 2015 | - | $168.44 M(+9.9%) |
| Mar 2015 | - | $153.33 M(-5.0%) |
| Dec 2014 | $4.66 M(-29.4%) | $161.32 M(+1.7%) |
| Sept 2014 | - | $158.60 M(-9.7%) |
| June 2014 | - | $175.62 M(-8.0%) |
| Mar 2014 | - | $190.91 M(+100.6%) |
| Dec 2013 | $6.60 M | $95.19 M(-7.4%) |
| Sept 2013 | - | $102.82 M(+2.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2013 | - | $100.42 M(-9.6%) |
| Mar 2013 | - | $111.11 M(-14.9%) |
| Dec 2012 | $4.10 M(+131.5%) | $130.63 M(+23.7%) |
| Sept 2012 | - | $105.62 M(-11.8%) |
| June 2012 | - | $119.73 M(-9.7%) |
| Mar 2012 | - | $132.57 M(+107.2%) |
| Dec 2011 | $1.77 M(-4.1%) | $63.99 M(-16.9%) |
| Sept 2011 | - | $76.97 M(-12.5%) |
| June 2011 | - | $88.01 M(+11.1%) |
| Mar 2011 | - | $79.19 M(-11.5%) |
| Dec 2010 | $1.85 M(-31.8%) | $89.50 M(-9.1%) |
| Sept 2010 | - | $98.43 M(+99.6%) |
| June 2010 | - | $49.32 M(-21.3%) |
| Mar 2010 | - | $62.68 M(-15.8%) |
| Dec 2009 | $2.71 M(+6.2%) | $74.44 M(-10.7%) |
| Sept 2009 | - | $83.41 M(-10.9%) |
| June 2009 | - | $93.65 M(+41.5%) |
| Mar 2009 | - | $66.18 M(-10.6%) |
| Dec 2008 | $2.55 M(+11.7%) | $74.01 M(-5.4%) |
| Sept 2008 | - | $78.23 M(-9.2%) |
| June 2008 | - | $86.12 M(-10.9%) |
| Mar 2008 | - | $96.62 M(-4.5%) |
| Dec 2007 | $2.28 M(+358.7%) | $101.18 M(-6.4%) |
| Sept 2007 | - | $108.08 M(+5.0%) |
| June 2007 | - | $102.94 M(+40.5%) |
| Mar 2007 | - | $73.29 M(+60.8%) |
| Dec 2006 | $497.80 K(+23.2%) | $45.59 M(+163.1%) |
| Sept 2006 | - | $17.33 M(+5.3%) |
| June 2006 | - | $16.45 M(-11.5%) |
| Mar 2006 | - | $18.58 M(-7.6%) |
| Dec 2005 | $404.10 K(+56.6%) | $20.11 M(+189.8%) |
| Sept 2005 | - | $6.94 M(-34.2%) |
| June 2005 | - | $10.55 M(-22.1%) |
| Mar 2005 | - | $13.54 M(-16.1%) |
| Dec 2004 | $258.00 K(>+9900.0%) | $16.15 M(+347.2%) |
| Sept 2004 | - | $3.61 M(-40.1%) |
| June 2004 | - | $6.03 M(-20.4%) |
| Mar 2004 | - | $7.57 M(+1402.9%) |
| Dec 2003 | - | $503.60 K(+666.5%) |
| Sept 2003 | - | $65.70 K(-9.5%) |
| June 2003 | - | $72.60 K(-21.1%) |
| Mar 2003 | - | $92.00 K(-17.7%) |
| Sept 2002 | - | $111.80 K(-8.7%) |
| June 2002 | - | $122.50 K(+223.2%) |
| Mar 2002 | - | $37.90 K |
| Dec 2001 | $0.00 | - |
FAQ
- What is Halozyme Therapeutics annual total current assets?
- What is the all time high annual current assets for Halozyme Therapeutics?
- What is Halozyme Therapeutics annual current assets year-on-year change?
- What is Halozyme Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Halozyme Therapeutics?
- What is Halozyme Therapeutics quarterly current assets year-on-year change?
What is Halozyme Therapeutics annual total current assets?
The current annual current assets of HALO is $746.42 M
What is the all time high annual current assets for Halozyme Therapeutics?
Halozyme Therapeutics all-time high annual total current assets is $926.29 M
What is Halozyme Therapeutics annual current assets year-on-year change?
Over the past year, HALO annual total current assets has changed by +$7.41 M (+1.00%)
What is Halozyme Therapeutics quarterly total current assets?
The current quarterly current assets of HALO is $1.13 B
What is the all time high quarterly current assets for Halozyme Therapeutics?
Halozyme Therapeutics all-time high quarterly total current assets is $1.13 B
What is Halozyme Therapeutics quarterly current assets year-on-year change?
Over the past year, HALO quarterly total current assets has changed by +$247.97 M (+28.21%)